Nuclear overexpression of the E2F3 transcription factor in human lung cancer
- 1 November 2006
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 54 (2) , 155-162
- https://doi.org/10.1016/j.lungcan.2006.07.005
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Differential disruption of cell cycle pathways in small cell and non-small cell lung cancerBritish Journal of Cancer, 2006
- E2F3a Stimulates Proliferation, p53-Independent Apoptosis and Carcinogenesis in a Transgenic Mouse ModelCell Cycle, 2005
- E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshortCell Death & Differentiation, 2005
- Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcomeOncogene, 2004
- E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancerOncogene, 2004
- Amplification and overexpression of E2F3 in human bladder cancerOncogene, 2003
- RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancerOncogene, 2002
- Quantitative expansion of structural genomic alterations in the spectrum of neuroendocrine lung carcinomasThe Journal of Pathology, 2002
- Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinomaOncogene, 2001
- PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancersOncogene, 1998